This New Drug Could Be Gilead Sciences’ Growth Catalyst
© The Motley Fool This new drug could be a catalyst for Gilead Sciences' growth Gilead Sciences (NASDAQ:GILD) is one of the year's biggest stocks, up 17%, while the S&P 500 is down 21% over the same period. And the company may have given investors reason to remain optimistic about the stock. Health officials have … Read more